TGTX
TG THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$53.30
−1.24%Margins
Gross margin
82.4%
EBITDA margin
16.8%
EBIT margin
17.1%
Net margin
55.2%
FCF margin
2.2%
73.1%
Return on equity
26.9%
Return on assets
10.0%
Return on invested capital
0.50x
Asset turnover
$17.9M
Cash from operations
$3.61
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026